PAR2 ZOLEDRONIC ACID IN THE LONG-TERM MANAGEMENT OF PAGET'S DISEASE OF THE BONE IN GERMANY-A COSTSAVING APPROACH?
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63261-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)63261-5/fulltext
Title :
PAR2 ZOLEDRONIC ACID IN THE LONG-TERM MANAGEMENT OF PAGET'S DISEASE OF THE BONE IN GERMANY-A COSTSAVING APPROACH?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63261-5&doi=10.1016/S1098-3015(10)63261-5
First page :
Section Title :
Open access? :
No
Section Order :
112